Fayetteville | 479-755-4510
Bentonville | 479-777-0657
Schedule Now

Glaucoma Visionaires - New Glaucoma Treatments*

Services ( View All )

World Leaders

As a world leader in glaucoma research and treatment, Dr. Steven Vold provides the most advanced medical, laser, and surgical care available in the field. Vold Vision has welcomed and served glaucoma patients from across the United States, as well as from those traveling abroad seeking the latest options in glaucoma care.

At Vold Vision, we believe this is an exciting time in the surgical treatment of glaucoma with the new micro-invasive glaucoma (MIGS) surgical devices available to surgeons. New glaucoma procedures, such as iStent, CyPass, XEN, Kahook Dual Blade, and the ABiC are changing patient outcomes and providing a better quality of life. Dr. Vold has performed more micro-invasive glaucoma surgery than almost anyone in the country and serves as a consultant to the development of many of these technologies.

Free Glaucoma Screenings Click Here

Learn About Glaucoma

Glaucoma affects adults from all walks of life. Although initial symptoms can be subtle, without a proper diagnosis and treatment plan, it can lead to blindness in many patients. Vold Vision is a leader in glaucoma research and development and we work with patients to manage this common, yet serious eye condition. To learn more about glaucoma, its symptoms, and the pioneering efforts of Dr. Vold we invite you to read more.

Do I Have Glaucoma? Click Here

Revolutionary Treatments

MIGS (Minimally Invasive Glaucoma Surgery) has changed the lives of thousands of glaucoma patients. Vold Vision under the extraordinary leadership of Dr. Vold has allowed our eye surgeons to offer a variety of MIGS treatments at our state-of-the-art vision center. MIGS treatments have allowed patients to have the quality of life they deserve and the opportunity to once again see clearly. While there are dozens of glaucoma treatments available today, ranging from medication to surgery, Vold Vision is known as leaders in MIGS research and development, and we are proud to offer several variations to our patients.

Learn More About iSTENT

Click Here

Learn More About CYPASS

Click Here

Learn More about XEN

Click Here

 

 

 

Additional Treatments

While MIGS is the most revolutionary treatment in the field of glaucoma, there a number of procedures available for patients to consider depending on their symptoms, stage of the disease, and age. It helps to understand all of the alternatives and to be reassured that there are many options to consider.

Additional Glaucoma Treatments Click Here

Award-Winning Surgeon

When diagnosed with glaucoma, the fear can be unsettling. Will I lose my vision? How long will I be able to see? What are my treatment options? These are common questions we get from our patients, and we are able to set their minds at ease because of the pioneering efforts and skill led by Dr. Vold. As a national and international leader in Glaucoma, Dr. Steven Vold provides the most advanced medical, laser, and surgical care available for treating glaucoma.

 

Amazing Outcomes

When patients undergo the new glaucoma treatments available today, they are not only stunned in the outcome but thankful. Just a few years ago, these options were not available and the results and prognosis not near as positive. Today, patients are excited and Dr. Vold and our team of glaucoma specialists are excited to play a part in this process.

Pioneering Efforts Recognized

Dr. Vold has been at the forefront of championing new glaucoma procedures. His passion for glaucoma patients and pioneering spirit has helped to usher a new wave of treatment options. He was the first surgeon in the United States to perform the CyPass in its initial FDA study, as well as the first surgeon in the United States to perform the procedure after it received FDA approval. Similarly, Dr. Vold performed the first XEN implant in the initial FDA clinical trial, and he was among the first surgeons in the United States and the first surgeon in the state of Arkansas to perform the surgery after the XEN received FDA approval. 

Because of these continuous outstanding pioneering efforts, Dr. Vold and our exceptional vision research facility has been highlighted time and time again in the media.

Dr. Vold serves as the Chief Medical Editor for the leading national glaucoma publication for physicians, Glaucoma Today. We invite you to take a look at his compelling monthly features and learn more about the exciting treatments for glaucoma patients. http://glaucomatoday.com/2017/04/chief-medical-editors-page

Request Consultation

Plan Your Procedure

Contact Us

*Individual results are not guaranteed and may vary from person to person. Images may contain models.